Clinical Trials, Industry, Research and Development, Vaccines
October 27, 2022
Via: GENA new study from scientists at La Jolla Institute for Immunology (LJI) has given researchers a guide to neutralizing the deadly Lassa virus (LSV) using a trio of rare antibodies isolated from survivors of Lassa virus infection. The LJI scientists […]
August 3, 2021
Via: PMLiVEThe FDA has expanded the use of Regeneron’s antibody cocktail, REGEN-COV, updating its emergency use authorisation (EUA) to include those at high risk of developing severe COVID-19 who have been exposed to the virus. The therapy – a combination of […]
Clinical Trials, Manufacturing, Research and Development
July 6, 2020
Via: Genetic Engineering and Biotechnology NewsRegeneron Pharmaceuticals said today its double-antibody cocktail against COVID-19 is advancing into Phase III studies, less than a month after the start of its first clinical trial, with preliminary data from one study expected to be reported later this summer. […]
July 11, 2024
July 11, 2024
July 19, 2024
Copyright © 2024. All rights reserved
